Metabolic rescue in pluripotent cells from patients with mtDNA disease
Hong Ma,
Clifford D. L. Folmes,
Jun Wu,
Robert Morey,
Sergio Mora-Castilla,
Alejandro Ocampo,
Li Ma,
Joanna Poulton,
Xinjian Wang,
Riffat Ahmed,
Eunju Kang,
Yeonmi Lee,
Tomonari Hayama,
Ying Li,
Crystal Van Dyken,
Nuria Marti Gutierrez,
Rebecca Tippner-Hedges,
Amy Koski,
Nargiz Mitalipov,
Paula Amato,
Don P. Wolf,
Taosheng Huang,
Andre Terzic,
Louise C. Laurent,
Juan Carlos Izpisua Belmonte and
Shoukhrat Mitalipov ()
Additional contact information
Hong Ma: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Clifford D. L. Folmes: Center for Regenerative Medicine and Department of Medicine, Division of Cardiovascular Diseases
Jun Wu: Gene Expression Laboratory, Salk Institute for Biological Studies
Robert Morey: University of California
Sergio Mora-Castilla: University of California
Alejandro Ocampo: Gene Expression Laboratory, Salk Institute for Biological Studies
Li Ma: Gene Expression Laboratory, Salk Institute for Biological Studies
Joanna Poulton: John Radcliffe Hospital, University of Oxford
Xinjian Wang: Cincinnati Children's Hospital Medical Center
Riffat Ahmed: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Eunju Kang: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Yeonmi Lee: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Tomonari Hayama: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Ying Li: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Crystal Van Dyken: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Nuria Marti Gutierrez: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Rebecca Tippner-Hedges: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Amy Koski: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Nargiz Mitalipov: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Paula Amato: Oregon Health and Science University
Don P. Wolf: Oregon National Primate Research Center, Oregon Health & Science University
Taosheng Huang: Cincinnati Children's Hospital Medical Center
Andre Terzic: Center for Regenerative Medicine and Department of Medicine, Division of Cardiovascular Diseases
Louise C. Laurent: University of California
Juan Carlos Izpisua Belmonte: Gene Expression Laboratory, Salk Institute for Biological Studies
Shoukhrat Mitalipov: Center for Embryonic Cell and Gene Therapy, Oregon Health & Science University
Nature, 2015, vol. 524, issue 7564, 234-238
Abstract:
Mutations in mitochondrial (mt)DNA are associated with severe disorders for which treatment is currently limited; this study shows that mtDNA mutations can be genetically corrected and normal metabolic function restored in cells derived from patients with mtDNA disease and reprogrammed to pluripotency through factor-mediated reprogramming or via a somatic cell nuclear transfer approach.
Date: 2015
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/nature14546 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:524:y:2015:i:7564:d:10.1038_nature14546
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature14546
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().